Federal contractor · CARLSBAD, CA

ARISAN THERAPEUTICS INC

ARISAN THERAPEUTICS INC received $2.9M in federal contract obligations in FY2026, on 2 awards. Since FY2020: $8.5M. Its largest customer was National Institutes of Health ($2.9M). It also received $1M in federal grants and other assistance in FY2026.

Obligations · FY2026
$2.9M
New awards
2
Sole-source
0.0%
Single offer
0.0%
UEI
PYRKTQPNVJZ8
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 263.6KFY2020
  2. 857.1KFY2021
  3. 769.4KFY2022
  4. 3.7MFY2023
  5. 2.9MFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$2.9M100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$2.9M100%

Where the work was performed

  1. San Diego County, CA$2.9M100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.$3.7M
    National Institutes of Health· San Diego County, CA· Research & development· Sep 18, 2023 – Jan 20, 2026· 75N93023C00051
  2. TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.$2.9M
    National Institutes of Health· San Diego County, CA· Research & development· Jul 29, 2026 – Jul 29, 2026· 75N93026C00012

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ARISAN THERAPEUTICS INC received $1M in federal assistance in FY2026, on 4 actions (0 new awards), −48% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($1M).

Assistance · FY2026
$1M
New awards
0
Actions
4
Since FY2021
$10.5M

Assistance by fiscal year

  1. 2.3MFY2021
  2. 2MFY2022
  3. 1.1MFY2023
  4. 2.1MFY2024
  5. 1.9MFY2025
  6. 1MFY2026

By type

  1. Grants$1M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$1M100%

Awarding agencies

  1. National Institutes of Health$1M100%
    Department of Health and Human Services

Largest awards

  1. IND-ENABLING STUDIES FOR ARENAVIRUS PRECLINICAL CANDIDATE - SUMMARY ARENAVIRUSES COMPRISE A DIVERSE FAMILY. SEVERAL SPECIES ARE ASSOCIATED…$5.5M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 13, 2021 – Apr 22, 2026· R01AI160246
  2. INITIATION OF ARN-75039 API AND DRUG PRODUCT NDA REGISTRATION PATH AND MANUFACTURING OF PHASE 3 FINAL DRUG PRODUCT - SUMMARY ARENAVIRUSES…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Mar 11, 2024 – Aug 27, 2026· SB1AI112097

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. SEABRIGHT LLC$2.9M−100% in FY2026
    SEATTLE, WA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. NOVOMEDIX LLC$3M−100% in FY2026
    SAN DIEGO, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. CONTINUITY BIOSCIENCES, LLC$3M−100% in FY2026
    BRADENTON, FL · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.